Damon Runyon Cancer Research Foundation
CatalogAbout
The Damon Runyon Cancer Research Foundation is a nonprofit organization dedicated to funding innovative cancer research. By identifying the nation's most promising scientists early in their careers and enabling them to pursue high-risk, high-reward projects, the foundation has contributed to nearly every major breakthrough in cancer research over the past 80 years. The organization focuses on supporting bold, groundbreaking approaches to understanding and treating cancer.
Funding Opportunities
Damon Runyon-Dale F. Frey Award for Breakthrough Scientists
The Damon Runyon-Dale F. Frey Award for Breakthrough Scientists provides additional investment in exceptional young scientists who have greatly exceeded expectations during their Damon Runyon Fellowship. These spectacular scientists are selected as those most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer. The award provides additional financial support to enable these scientists to continue the pursuit of bold and innovative ideas, accelerate the path to independence, and encourage a continued career in cancer research. The award is designed to catapult the research careers and impact on cancer of these exceptional individuals who have demonstrated exceptional productivity and significant accomplishments during their Fellowship. Selection is based on exceptional productivity during the Fellowship, potential to become a leader in cancer research, and potential of the research to impact cancer prevention, diagnosis, or treatment.
Damon Runyon-Rachleff Innovation Award
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with 'high-risk/high-reward' ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. The Stage 1 award provides two years of funding at $200,000 per year ($400,000 total) with the opportunity for up to two additional years of funding for a select few Innovators who demonstrate the most significant progress on their innovative research (up to four years total for $800,000). Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators and are approved by the Board of Directors acting upon the recommendation of the Innovation Award Committee.
At a Glance
- Total Funding Opportunities
- 7
- Active Now
- 2
- Source Domain
- damonrunyon.org
Catalog Data
This funder profile was automatically extracted from grant listings. Information may be incomplete.
Visit official website